CIA Director William Burns tests positive for Covid after meeting with Biden, but is not considered a close contact

CIA Director William Burns tests positive for Covid after meeting with Biden, but is not considered a close contact


CIA Director Bill Burns testifies next to Director of National Intelligence Avril Haines during a House (Select) Intelligence Committee hearing on diversity in the intelligence community, on Capitol Hill in Washington, October 27, 2021.

Elizabeth Frantz | Reuters

WASHINGTON – CIA Director William Burns tested positive for Covid-19 on Thursday, the intelligence agency said.

Burns, who is fully vaccinated and boosted against Covid-19, last met with President Joe Biden on Wednesday morning during a “socially distanced meeting and was wearing an N-95 mask.”

“Their interaction is not considered close contact as defined by CDC guidance, and Director Burns is sharing the news of his positive test out of an abundance of transparency,” the intelligence agency wrote in a statement.

Burns will continue to perform his duties as CIA director but will work from home. He will return to the office following a negative test and after isolating for five days. The agency said that Burns has experienced mild symptoms.

Burns’ positive test follows two other virus cases within Biden’s orbit.

On Sunday, White House deputy press secretary Karine Jean-Pierre said she tested positive for Covid-19. Her positive test result came several days after White House press secretary Jen Psaki tested positive for the virus, which prevented her from traveling with Biden to Belgium and Poland.

Psaki said at the time that Biden was not considered a close contact following two socially distanced meetings.

Earlier this month, second gentleman Doug Emhoff tested positive for Covid-19. Following the positive test result, the White House said that Vice President Kamala Harris would skip a scheduled event “out of an abundance of caution.”

Biden, 79, received his fourth dose of the coronavirus vaccine on Wednesday.



Source

Making U.S. biotech more competitive with China’s could help rare disease patients, experts say
Health

Making U.S. biotech more competitive with China’s could help rare disease patients, experts say

The growth of China’s biotechnology sector has been staggering. Beijing is pumping money into the industry, backing research efforts and helping launch a new wave of labs and incubators in the country. That’s a problem for the U.S. biotech industry and also affects rare disease patients who are waiting for a cure. Among the experts […]

Read More
Healthy Returns: Novo Nordisk CEO on GLP-1 pricing, and more insights from the JPM conference
Health

Healthy Returns: Novo Nordisk CEO on GLP-1 pricing, and more insights from the JPM conference

A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions. Good morning from San Francisco! It’s day three of the annual JPMorgan Healthcare Conference – the biggest gathering of biotech and pharma execs, investors and analysts in […]

Read More
OpenAI acquires health-care technology startup Torch
Health

OpenAI acquires health-care technology startup Torch

OpenAI has acquired the health-care technology startup Torch, the company announced on Monday. Torch was building a “unified medical memory” for artificial intelligence that aimed to bring a patient’s health data, which is typically siloed and stored across a number of different vendors and formats, into one place. Torch’s employees will join OpenAI as part […]

Read More